Yifan Pharmaceutical Co., Ltd.

SZSE:002019 Stock Report

Market Cap: CN¥15.8b

Yifan Pharmaceutical Balance Sheet Health

Financial Health criteria checks 4/6

Yifan Pharmaceutical has a total shareholder equity of CN¥8.3B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 23.4%. Its total assets and total liabilities are CN¥11.8B and CN¥3.4B respectively. Yifan Pharmaceutical's EBIT is CN¥91.7M making its interest coverage ratio 1.5. It has cash and short-term investments of CN¥835.6M.

Key information

23.4%

Debt to equity ratio

CN¥1.95b

Debt

Interest coverage ratio1.5x
CashCN¥835.56m
EquityCN¥8.35b
Total liabilitiesCN¥3.43b
Total assetsCN¥11.78b

Recent financial health updates

Recent updates

These 4 Measures Indicate That Yifan Pharmaceutical (SZSE:002019) Is Using Debt Extensively

Jun 04
These 4 Measures Indicate That Yifan Pharmaceutical (SZSE:002019) Is Using Debt Extensively

Yifan Pharmaceutical Co., Ltd.'s (SZSE:002019) Shares Leap 28% Yet They're Still Not Telling The Full Story

May 08
Yifan Pharmaceutical Co., Ltd.'s (SZSE:002019) Shares Leap 28% Yet They're Still Not Telling The Full Story

A Piece Of The Puzzle Missing From Yifan Pharmaceutical Co., Ltd.'s (SZSE:002019) Share Price

Mar 01
A Piece Of The Puzzle Missing From Yifan Pharmaceutical Co., Ltd.'s (SZSE:002019) Share Price

Financial Position Analysis

Short Term Liabilities: 002019's short term assets (CN¥3.5B) exceed its short term liabilities (CN¥2.5B).

Long Term Liabilities: 002019's short term assets (CN¥3.5B) exceed its long term liabilities (CN¥954.8M).


Debt to Equity History and Analysis

Debt Level: 002019's net debt to equity ratio (13.4%) is considered satisfactory.

Reducing Debt: 002019's debt to equity ratio has increased from 21.7% to 23.4% over the past 5 years.

Debt Coverage: 002019's debt is well covered by operating cash flow (27%).

Interest Coverage: 002019's interest payments on its debt are not well covered by EBIT (1.5x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.